Prime Medicine, Inc.
PRME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $346 | $806 | $1,806 | $998 |
| - Cash | $182 | $42 | $188 | $185 |
| + Debt | $41 | $14 | $29 | $10 |
| Enterprise Value | $205 | $778 | $1,647 | $822 |
| Revenue | $3 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $3 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$196 | -$187 | -$114 | -$84 |
| % Margin | -6,581.9% | – | – | – |
| Net Income | -$196 | -$198 | -$122 | -$165 |
| % Margin | -6,566.6% | – | – | – |
| EPS Diluted | -1.652 | -2.178 | -1.461 | -1.923 |
| % Growth | 24.2% | -49.1% | 24% | – |
| Operating Cash Flow | -$123 | -$165 | -$132 | -$34 |
| Capital Expenditures | -$7 | -$9 | -$16 | -$4 |
| Free Cash Flow | -$130 | -$174 | -$148 | -$38 |